Renaissance Technologies’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-45,000
Closed -$84K 4488
2022
Q4
$84K Sell
45,000
-81,002
-64% -$127K ﹤0.01% 3675
2022
Q3
$161K Buy
+126,002
New +$274K ﹤0.01% 3454
2021
Q3
Sell
-8,200
Closed -$253K 3934
2021
Q2
$253K Buy
+8,200
New +$245K ﹤0.01% 3197

Other funds holding RNLX

Renaissance Technologies's RNLX Position: Q1 2023 in Review

Renaissance Technologies sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2023, closing a stake of 45,000 shares — an estimated $84K sold.

Renaissance Technologies first reported a position in RNLX in Q2 2021 and held it in 3 quarters. The position peaked at $253K in Q2 2021. 18 funds tracked by Wall St. Rank hold RNLX as of Q1 2023.

  • Renaissance Technologies reported no remaining Renalytix plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Renaissance Technologies sold 45,000 Renalytix plc American Depositary Shares shares in Q1 2023, an estimated $84K.
  • Renaissance Technologies first reported a position in Renalytix plc American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • Renaissance Technologies's Renalytix plc American Depositary Shares position peaked at $253K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.